The White House reported that up to 60 million US AstraZeneca doses would be diverted to other countries when they become available.
After federal authorities review their safety requirements, these doses will be eligible for export in the coming months.
Despite the desperate need for the vaccine in other nations, the US has been accused of stockpiling vast amounts of the vaccine.
Last month, US Vice President Joe Biden promised to send about 4 million doses of the AstraZeneca vaccine to Canada and Mexico, with both countries agreeing to use it.
After the Food and Drug Administration completes its study, the White House expects around 10 million AstraZeneca doses to be available in the coming weeks, according to a statement released Monday.
Around 50 million doses were in different stages of development, according to the White House.
FDA officials will ensure the doses are secure before shipping them, according to White House spokeswoman Jane Sackey.
“Our team will publish more information about our strategy and who will receive offers from here,” she said, “but we are currently in the process of preparing.”
The United States recently announced that it would quickly supply vaccine factories in India with basic materials, after announcing record rates of infection cases.
After reporting record rates of infection cases, the United States recently declared that it would rapidly supply essential materials to vaccine factories in India.
In response to Biden’s call to Indian Prime Minister Narendra Modi, the White House issued a denial.
He went on to say that US president promised to provide more emergency assistance, including “oxygen supplies, vaccine products, and treatments.
The decision to export up to 60 million doses of the AstraZeneca vaccine – which is still pending approval in the United States – comes at a crucial time, as both Canada and Mexico are grappling with the pandemic, and India is seeing a massive rise in the number of infections.
The step provides an opening for the Biden administration to engage in “vaccine diplomacy” and pressure other countries to do the same.
At the very least, this absolves Biden of charges that the US is turning its back on the world at a time when it has millions of life-saving drugs.
As long as US vaccine supplies are secure, President Biden appears to be safe from internal threats. This demonstrates the administration’s belief that the next issue will be a shortage of vaccines.